One Medical got off to a strong start on Friday after launching its IPO at $14 per share. The membership-based primary care provider came to the table with an ambitious business proposition: that primary care, the ugly duckling of the healthcare industry, can use technology and high-end customer service to draw in patients willing to pay a little extra.

"If you want to keep people healthier, happier, and frankly give them the option to be their healthiest self, as healthy as they can be, you've got to start with primary care, and in order to do that you've got to make it accessible," CFO Bjorn Thaler told Cheddar.

Primary care in the U.S.has gained a reputation in recent years for long wait times, difficult scheduling, and overworked doctors who don't have enough time for patients.

One Medical's pitch is that for $200 per year members get access to a calm and comfortable patient experience through modernized doctors' offices and proprietary software and apps that streamline scheduling and provide easier access to health records.

The company, founded in 2007, built its reputation in the San Francisco-Bay Area before expanding to 77 locations in eight cities with a total of 397,000 members and 6,000 employer partners.

Several rounds of investment from the likes Google Ventures and The Carlyle Group lifted One Medical's value to nearly $2 billion over the last two years, but an ambitious and expensive growth plan pushed the company to go public.

"We're taking this model to 12 different geographics, including places like Atlanta, Portland and Orange County, over the next 18 months," Thaler said. "In order to do that and continue to fuel our growth, we decided to raise capital, and we decided to raise capital in the public markets."

The stock surged to over $20 per share at midday — a robust opening that came despite the fact that One Medical posted net losses of $32 million in 2017 and $46 million in 2018.

Talk of tech and convenience, however, can make it easy to forget that One Medical is still operating in the costly and highly regulated health care space.

"We are in this to disrupt healthcare," Thaler said. "It's not something that we are going to do in a month or a year. This is going to take time. We are in this for the long-run."

What if health care gets disrupted first? Thaler is confident that One Medical can weather any major reforms, including Democratic candidate Sen. Bernie Sanders' plan to implement a single-payer health insurance program.

Regardless of how health care is financed, he said, people still want a comfortable and convenient primary care experience.

"I think we are on the right side of healthcare reform, regardless of which way it goes," he said.

Share:
More In Business
Hard pass, Cold brew, Dad bod: Merriam-Webster adds 5,000 new words
Merriam-Webster has fully revised its popular “Collegiate” dictionary with over 5,000 new words. They include “petrichor,” “dumbphone” and “ghost kitchen.” Also “cold brew,” “rizz,” “dad bod,” “hard pass,” “cancel culture” and more.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More